Vertex CEO Jeff Leiden to step down
July 25, 2019 at 09:32 AM EDT
During his seven year tenure, Leiden has led Vertex through the transition from a hepatitis C drugmaker to the first company to produce an FDA-approved treatment for the rare lung condition cystic fibrosis.